Cybin Inc. (CYBN)

USD 9.46

(-0.11%)

Total Debt Summary of Cybin Inc.

  • Cybin Inc.'s latest annual total debt in 2023 was 291 Thousand CAD , down 0.0% from previous year.
  • Cybin Inc.'s latest quarterly total debt in 2024 Q1 was 212 Thousand CAD , down -27.15% from previous quarter.
  • Cybin Inc. reported annual total debt of - CAD in 2022, down 0.0% from previous year.
  • Cybin Inc. reported annual total debt of - CAD in 2021, down 0.0% from previous year.
  • Cybin Inc. reported quarterly total debt of 366 Thousand CAD for 2023 Q3, down 0.0% from previous quarter.
  • Cybin Inc. reported quarterly total debt of 291 Thousand CAD for 2023 FY, down 0.0% from previous quarter.

Annual Total Debt Chart of Cybin Inc. (2023 - 2016)

Historical Annual Total Debt of Cybin Inc. (2023 - 2016)

Year Total Debt Total Debt Growth
2023 291 Thousand CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%

Peer Total Debt Comparison of Cybin Inc.

Name Total Debt Total Debt Difference
AIM ImmunoTech Inc. 495 Thousand USD 41.212%
Ampio Pharmaceuticals, Inc. 274 Thousand USD -6.204%
Armata Pharmaceuticals, Inc. 120.37 Million USD 99.758%
Actinium Pharmaceuticals, Inc. 2.11 Million USD 86.228%
Azitra, Inc. 885.94 Thousand USD 67.154%
Can-Fite BioPharma Ltd. 39.99 Thousand USD -627.518%
Chromocell Therapeutics Corporation 1.26 Million USD 77.063%
Calidi Biotherapeutics, Inc. 7.23 Million USD 95.978%
CEL-SCI Corporation 13.57 Million USD 97.856%
iBio, Inc. 4.46 Million USD 93.475%
Lineage Cell Therapeutics, Inc. 2.95 Million USD 90.142%
MAIA Biotechnology, Inc. - USD -Infinity%
Matinas BioPharma Holdings, Inc. 3.55 Million USD 91.817%
Navidea Biopharmaceuticals, Inc. 2.43 Million USD 88.046%
NovaBay Pharmaceuticals, Inc. 2.74 Million USD 89.38%
NanoViricides, Inc. - USD -Infinity%
Oragenics, Inc. 312.7 Thousand USD 6.94%
BiomX Inc. 15.09 Million USD 98.072%
BiomX Inc. 15.09 Million USD 98.072%
Protalix BioTherapeutics, Inc. 26.28 Million USD 98.893%
Palatin Technologies, Inc. 590.33 Thousand USD 50.706%
Scorpius Holdings, Inc. 14.04 Million USD 97.928%